Back to Trades
Sell4
Viking Therapeutics, Inc.
VKTX
Total Value
$1.4M
Net $561.7K sold
Sales
$561.7K
1 transaction
Company Information
- Company Name
- Viking Therapeutics, Inc.
- Ticker Symbol
- VKTX
- CIK
- 0001607678
Insider Information
- Name
- FOEHR MATTHEW W
- Role
- Insider
- Location
- SAN DIEGO, CA
Filing Details
- Filing Date
- Jan 5, 2026
- Transaction Date
- Jan 2, 2026
- Accession Number
- 0001193125-26-003109
- Form Type
- 4
- Net Trading Amount
- -$561.7K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock, par value $0.00001 per share | 16,000 | $3.33 | Exercise | $53.3K |
| Jan 2, 2026 | Common Stock, par value $0.00001 per share | 16,000 | $35.11 | Sale | $561.7K |
| Jan 2, 2026 | Common Stock, par value $0.00001 per share | 3,150 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Derivative | 16,000 | $3.33 | Exercise | $53.3K |
| Jan 2, 2026 | Derivative | 20,400 | $35.42 | Grant/Award | $722.6K |
Footnotes
- (F1)The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $34.94 to $35.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- (F2)Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2024 Equity Incentive Plan. All shares subject to the RSU shall vest on the one year anniversary of the grant date of the award.